Despite the progress of the past two decades, the cause of Alzheimer's disease (AD) and effective treatments against it remain elusive. The hypothesis that amyloid-β (Aβ) peptides are the primary causative agents of AD retains significant support among researchers. Nonetheless, a growing body of evidence shows that Aβ peptides are unlikely to be the sole factor in AD etiology. Evidence that Aβ/amyloid-independent factors, including the actions of AD-related genes, also contribute significantly to AD pathogenesis was presented in a symposium at the 2010 Annual Meeting of the Society for Neuroscience. Here we summarize the studies showing how amyloid-independent mechanisms cause defective endo-lysosomal trafficking, altered intracellular signaling cascades, or impaired neurotransmitter release and contribute to synaptic dysfunction and/or neurodegeneration, leading to dementia in AD. A view of AD pathogenesis that encompasses both the amyloid-dependent and -independent mechanisms will help fill the gaps in our knowledge and reconcile the findings that cannot be explained solely by the amyloid hypothesis. Copyright © 2010 the authors.
CITATION STYLE
Pimplikar, S. W., Nixon, R. A., Robakis, N. K., Shen, J., & Tsai, L. H. (2010). Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis. In Journal of Neuroscience (Vol. 30, pp. 14946–14954). https://doi.org/10.1523/JNEUROSCI.4305-10.2010
Mendeley helps you to discover research relevant for your work.